NEA Management Company as of March 31, 2018
Portfolio Holdings for NEA Management Company
NEA Management Company holds 43 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 26.5 | $595M | 10M | 57.14 | |
| Crispr Therapeutics (CRSP) | 7.1 | $159M | 3.5M | 45.71 | |
| Adaptimmune Therapeutics (ADAP) | 6.7 | $150M | 13M | 11.23 | |
| Glycomimetics (GLYC) | 6.2 | $139M | 8.6M | 16.23 | |
| Mersana Therapeutics (MRSN) | 5.7 | $128M | 8.1M | 15.77 | |
| Epizyme | 5.1 | $115M | 6.5M | 17.75 | |
| Rhythm Pharmaceuticals (RYTM) | 4.3 | $98M | 4.9M | 19.90 | |
| Senseonics Hldgs (SENS) | 4.1 | $93M | 31M | 3.00 | |
| Ardelyx (ARDX) | 3.2 | $71M | 14M | 5.05 | |
| Achaogen | 3.0 | $68M | 5.2M | 12.95 | |
| Obseva Sa | 2.8 | $62M | 4.6M | 13.50 | |
| AVEO Pharmaceuticals | 2.1 | $48M | 16M | 2.90 | |
| Arsanis | 2.0 | $46M | 2.0M | 22.89 | |
| Immunomedics | 1.8 | $41M | 2.8M | 14.61 | |
| Synlogic | 1.8 | $40M | 4.2M | 9.38 | |
| Strongbridge Bioph shs usd | 1.6 | $37M | 4.1M | 8.85 | |
| Clementia | 1.4 | $32M | 2.1M | 15.15 | |
| Ra Pharmaceuticals | 1.3 | $29M | 5.5M | 5.31 | |
| Dermira | 1.2 | $28M | 3.5M | 7.99 | |
| Genocea Biosciences | 1.2 | $26M | 25M | 1.05 | |
| Proteostasis Therapeutics In | 1.2 | $26M | 5.6M | 4.75 | |
| Aurinia Pharmaceuticals (AUPH) | 1.1 | $25M | 4.8M | 5.19 | |
| Verona Pharma Plc ads (VRNA) | 1.1 | $24M | 1.2M | 20.00 | |
| Lexicon Pharmaceuticals (LXRX) | 0.9 | $20M | 2.4M | 8.57 | |
| Cti Biopharma | 0.7 | $15M | 3.8M | 3.90 | |
| Erytech Pharma Sa | 0.6 | $13M | 625k | 21.00 | |
| Rigel Pharmaceuticals (RIGL) | 0.5 | $12M | 3.2M | 3.54 | |
| Dasan Zhone Solutions | 0.5 | $11M | 956k | 11.44 | |
| Endologix | 0.5 | $11M | 2.5M | 4.23 | |
| Nightstar Therapeutics | 0.5 | $10M | 714k | 14.31 | |
| Affimed Therapeutics B V | 0.4 | $9.5M | 5.1M | 1.85 | |
| Trillium Therapeutics, Inc. Cmn | 0.4 | $9.0M | 1.3M | 7.20 | |
| Tintri Inc. equity | 0.4 | $9.0M | 5.3M | 1.71 | |
| Regulus Therapeutics | 0.3 | $7.9M | 11M | 0.72 | |
| Tracon Pharmaceuticals | 0.3 | $8.0M | 3.5M | 2.30 | |
| ArQule | 0.3 | $7.3M | 2.5M | 2.88 | |
| Mongodb Inc. Class A (MDB) | 0.3 | $6.5M | 150k | 43.40 | |
| Trevena | 0.3 | $6.3M | 3.8M | 1.64 | |
| Champions Oncology (CSBR) | 0.2 | $5.7M | 1.6M | 3.64 | |
| Aquantia Corp | 0.2 | $3.8M | 240k | 15.70 | |
| Sunesis Pharmaceuticals Inc Ne | 0.2 | $3.5M | 1.3M | 2.72 | |
| Akari Therapeutics | 0.0 | $823k | 452k | 1.82 | |
| Aytu Bioscience | 0.0 | $29k | 45k | 0.65 |
